|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 101 to 200 out of 402 for Synj2

Category restricted to Publication (x)

0.035s

Categories

Category: Publication
Type Details Score
Publication
First Author: Trazzi S
Year: 2011
Journal: Hum Mol Genet
Title: APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndrome.
Volume: 20
Issue: 8
Pages: 1560-73
Publication
First Author: Contestabile A
Year: 2013
Journal: J Clin Invest
Title: Lithium rescues synaptic plasticity and memory in Down syndrome mice.
Volume: 123
Issue: 1
Pages: 348-61
Publication
First Author: Holtzman DM
Year: 1996
Journal: Proc Natl Acad Sci U S A
Title: Developmental abnormalities and age-related neurodegeneration in a mouse model of Down syndrome.
Volume: 93
Issue: 23
Pages: 13333-8
Publication
First Author: Martinez de Lagran M
Year: 2022
Journal: J Cell Mol Med
Title: Lamivudine, a reverse transcriptase inhibitor, rescues cognitive deficits in a mouse model of down syndrome.
Volume: 26
Issue: 15
Pages: 4210-4215
Publication
First Author: Rueda N
Year: 2008
Journal: Behav Brain Res
Title: Effects of chronic administration of SGS-111 during adulthood and during the pre- and post-natal periods on the cognitive deficits of Ts65Dn mice, a model of Down syndrome.
Volume: 188
Issue: 2
Pages: 355-67
Publication  
First Author: Corrales A
Year: 2017
Journal: Behav Brain Res
Title: Pre- and post-natal melatonin administration partially regulates brain oxidative stress but does not improve cognitive or histological alterations in the Ts65Dn mouse model of Down syndrome.
Volume: 334
Pages: 142-154
Publication
First Author: Reinholdt LG
Year: 2011
Journal: Mamm Genome
Title: Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn.
Volume: 22
Issue: 11-12
Pages: 685-91
Publication
First Author: Keck-Wherley J
Year: 2011
Journal: Dev Neurosci
Title: Abnormal microRNA expression in Ts65Dn hippocampus and whole blood: contributions to Down syndrome phenotypes.
Volume: 33
Issue: 5
Pages: 451-67
Publication
First Author: Hamlett ED
Year: 2020
Journal: Glia
Title: RvE1 treatment prevents memory loss and neuroinflammation in the Ts65Dn mouse model of Down syndrome.
Volume: 68
Issue: 7
Pages: 1347-1360
Publication
First Author: Dierssen M
Year: 2003
Journal: Cereb Cortex
Title: Alterations of neocortical pyramidal cell phenotype in the Ts65Dn mouse model of Down syndrome: effects of environmental enrichment.
Volume: 13
Issue: 7
Pages: 758-64
Publication
First Author: Necchi D
Year: 2011
Journal: Exp Neurol
Title: Dysfunction of the ubiquitin-proteasome system in the cerebellum of aging Ts65Dn mice.
Volume: 232
Issue: 2
Pages: 114-8
Publication
First Author: Spellman C
Year: 2013
Journal: Gene
Title: Expression of trisomic proteins in Down syndrome model systems.
Volume: 512
Issue: 2
Pages: 219-25
Publication
First Author: Contestabile A
Year: 2009
Journal: Brain Pathol
Title: Cell cycle elongation impairs proliferation of cerebellar granule cell precursors in the Ts65Dn mouse, an animal model for Down syndrome.
Volume: 19
Issue: 2
Pages: 224-37
Publication
First Author: Martínez-Cué C
Year: 2005
Journal: Behav Brain Res
Title: Behavioral, cognitive and biochemical responses to different environmental conditions in male Ts65Dn mice, a model of Down syndrome.
Volume: 163
Issue: 2
Pages: 174-85
Publication
First Author: Alldred MJ
Year: 2015
Journal: J Comp Neurol
Title: Expression profile analysis of vulnerable CA1 pyramidal neurons in young-Middle-Aged Ts65Dn mice.
Volume: 523
Issue: 1
Pages: 61-74
Publication
First Author: Escorihuela RM
Year: 1995
Journal: Neurosci Lett
Title: A behavioral assessment of Ts65Dn mice: a putative Down syndrome model.
Volume: 199
Issue: 2
Pages: 143-6
Publication
First Author: Rueda N
Year: 2008
Journal: Neurosci Lett
Title: Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome.
Volume: 433
Issue: 1
Pages: 22-7
Publication
First Author: Sanders NC
Year: 2009
Journal: Behav Brain Res
Title: Does the learning deficit observed under an incremental repeated acquisition schedule of reinforcement in Ts65Dn mice, a model for Down syndrome, change as they age?
Volume: 203
Issue: 1
Pages: 137-42
Publication
First Author: Dowdy-Sanders NC
Year: 2006
Journal: Behav Brain Res
Title: Working memory in the Ts65Dn mouse, a model for Down syndrome.
Volume: 168
Issue: 2
Pages: 349-52
Publication
First Author: Strovel J
Year: 1999
Journal: Cytogenet Cell Genet
Title: Interphase FISH for rapid identification of a down syndrome animal model.
Volume: 86
Issue: 3-4
Pages: 285-7
Publication
First Author: Reeves RH
Year: 1995
Journal: Nat Genet
Title: A mouse model for Down syndrome exhibits learning and behaviour deficits.
Volume: 11
Issue: 2
Pages: 177-84
Publication
First Author: Siarey RJ
Year: 1997
Journal: Neuropharmacology
Title: Altered long-term potentiation in the young and old Ts65Dn mouse, a model for Down Syndrome.
Volume: 36
Issue: 11-12
Pages: 1549-54
Publication
First Author: Ruiz de Azúa I
Year: 2001
Journal: J Neurosci Res
Title: Reduced phospholipase C-beta activity and isoform expression in the cerebellum of TS65Dn mouse: a model of Down syndrome.
Volume: 66
Issue: 4
Pages: 540-50
Publication
First Author: Siarey RJ
Year: 1997
Journal: Neurosci Lett
Title: Responses to NMDA in cultured hippocampal neurons from trisomy 16 embryonic mice.
Volume: 232
Issue: 3
Pages: 131-4
Publication
First Author: Higuera C
Year: 2015
Journal: PLoS One
Title: Self-Organizing Feature Maps Identify Proteins Critical to Learning in a Mouse Model of Down Syndrome.
Volume: 10
Issue: 6
Pages: e0129126
Publication  
First Author: García-Cerro S
Year: 2018
Journal: Neurobiol Dis
Title: Cerebellar alterations in a model of Down syndrome: The role of the Dyrk1A gene.
Volume: 110
Pages: 206-217
Publication
First Author: Seo H
Year: 2005
Journal: Exp Neurol
Title: Abnormal APP, cholinergic and cognitive function in Ts65Dn Down's model mice.
Volume: 193
Issue: 2
Pages: 469-80
Publication
First Author: Arriagada C
Year: 2010
Journal: Neurosci Lett
Title: Apoptosis is directly related to intracellular amyloid accumulation in a cell line derived from the cerebral cortex of a trisomy 16 mouse, an animal model of Down syndrome.
Volume: 470
Issue: 1
Pages: 81-5
Publication
First Author: Llorens-Martín MV
Year: 2010
Journal: Neuroscience
Title: Effects of voluntary physical exercise on adult hippocampal neurogenesis and behavior of Ts65Dn mice, a model of Down syndrome.
Volume: 171
Issue: 4
Pages: 1228-40
Publication  
First Author: Duchon A
Year: 2022
Journal: Dis Model Mech
Title: Ts66Yah, a mouse model of Down syndrome with improved construct and face validity.
Volume: 15
Issue: 12
Publication
First Author: Chang Q
Year: 2008
Journal: Neurobiol Learn Mem
Title: Age-related changes in memory and in acetylcholine functions in the hippocampus in the Ts65Dn mouse, a model of Down syndrome.
Volume: 89
Issue: 2
Pages: 167-77
Publication  
First Author: Stagni F
Year: 2016
Journal: Neuroscience
Title: Short- and long-term effects of neonatal pharmacotherapy with epigallocatechin-3-gallate on hippocampal development in the Ts65Dn mouse model of Down syndrome.
Volume: 333
Pages: 277-301
Publication
First Author: Fortress AM
Year: 2015
Journal: J Neurosci
Title: Designer receptors enhance memory in a mouse model of Down syndrome.
Volume: 35
Issue: 4
Pages: 1343-53
Publication
First Author: Incerti M
Year: 2012
Journal: PLoS One
Title: Prenatal treatment prevents learning deficit in Down syndrome model.
Volume: 7
Issue: 11
Pages: e50724
Publication
First Author: Stasko MR
Year: 2006
Journal: Neuroreport
Title: Hypothermic responses to 8-OH-DPAT in the Ts65Dn mouse model of Down syndrome.
Volume: 17
Issue: 8
Pages: 837-41
Publication      
First Author: Guedj F
Year: 2023
Journal: Biol Psychiatry
Title: The Impact of Mmu17 Non-Hsa21 Orthologous Genes in the Ts65Dn Mouse Model of Down Syndrome: The Gold Standard Refuted.
Publication
First Author: Letourneau A
Year: 2014
Journal: Nature
Title: Domains of genome-wide gene expression dysregulation in Down's syndrome.
Volume: 508
Issue: 7496
Pages: 345-50
Publication
First Author: Driscoll LL
Year: 2004
Journal: Behav Neurosci
Title: Impaired sustained attention and error-induced stereotypy in the aged Ts65Dn mouse: a mouse model of Down syndrome and Alzheimer's disease.
Volume: 118
Issue: 6
Pages: 1196-205
Publication  
First Author: Lomoio S
Year: 2009
Journal: Brain Res
Title: Beta-amyloid overload does not directly correlate with SAPK/JNK activation and tau protein phosphorylation in the cerebellar cortex of Ts65Dn mice.
Volume: 1297
Pages: 198-206
Publication
First Author: Hyde LA
Year: 2001
Journal: Behav Neurosci
Title: Age-related deficits in context discrimination learning in Ts65Dn mice that model Down syndrome and Alzheimer's disease.
Volume: 115
Issue: 6
Pages: 1239-46
Publication
First Author: Martínez-Cué C
Year: 1999
Journal: Neuroreport
Title: A murine model for Down syndrome shows reduced responsiveness to pain.
Volume: 10
Issue: 5
Pages: 1119-22
Publication
First Author: Costa AC
Year: 2005
Journal: Neurosci Lett
Title: Deficits in hippocampal CA1 LTP induced by TBS but not HFS in the Ts65Dn mouse: a model of Down syndrome.
Volume: 382
Issue: 3
Pages: 317-22
Publication
First Author: Sahir N
Year: 2006
Journal: J Mol Neurosci
Title: Neonatal mice of the Down syndrome model, Ts65Dn, exhibit upregulated VIP measures and reduced responsiveness of cortical astrocytes to VIP stimulation.
Volume: 30
Issue: 3
Pages: 329-40
Publication
First Author: Goodlett CR
Year: 2020
Journal: Sci Rep
Title: Evaluation of the therapeutic potential of Epigallocatechin-3-gallate (EGCG) via oral gavage in young adult Down syndrome mice.
Volume: 10
Issue: 1
Pages: 10426
Publication
First Author: Vorbrodt AW
Year: 2008
Journal: Brain Cell Biol
Title: Increased expression of beta-catenin in brain microvessels of a segmentally trisomic (Ts65Dn) mouse model of Down syndrome.
Volume: 36
Issue: 5-6
Pages: 203-11
Publication
First Author: Liu DP
Year: 2003
Journal: Biotechniques
Title: Quantitative PCR genotyping assay for the Ts65Dn mouse model of Down syndrome.
Volume: 35
Issue: 6
Pages: 1170-4, 1176, 1178 passim
Publication
First Author: Richtsmeier JT
Year: 2000
Journal: Dev Dyn
Title: Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice.
Volume: 217
Issue: 2
Pages: 137-45
Publication  
First Author: Duval N
Year: 2018
Journal: Front Aging Neurosci
Title: Rapamycin Treatment Ameliorates Age-Related Accumulation of Toxic Metabolic Intermediates in Brains of the Ts65Dn Mouse Model of Down Syndrome and Aging.
Volume: 10
Pages: 263
Publication
First Author: Deidda G
Year: 2015
Journal: Nat Med
Title: Reversing excitatory GABAAR signaling restores synaptic plasticity and memory in a mouse model of Down syndrome.
Volume: 21
Issue: 4
Pages: 318-26
Publication
First Author: Lockrow J
Year: 2009
Journal: Exp Neurol
Title: Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model.
Volume: 216
Issue: 2
Pages: 278-89
Publication
First Author: Galdzicki Z
Year: 2001
Journal: Brain Res Brain Res Rev
Title: On the cause of mental retardation in Down syndrome: extrapolation from full and segmental trisomy 16 mouse models.
Volume: 35
Issue: 2
Pages: 115-45
Publication  
First Author: Gautier MK
Year: 2023
Journal: Neurobiol Dis
Title: Maternal choline supplementation protects against age-associated cholinergic and GABAergic basal forebrain neuron degeneration in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.
Volume: 188
Pages: 106332
Publication  
First Author: Giacomini A
Year: 2015
Journal: Neurobiol Dis
Title: Inhibition of APP gamma-secretase restores Sonic Hedgehog signaling and neurogenesis in the Ts65Dn mouse model of Down syndrome.
Volume: 82
Pages: 385-396
Publication  
First Author: Begenisic T
Year: 2015
Journal: Neurobiol Dis
Title: Early environmental therapy rescues brain development in a mouse model of Down syndrome.
Volume: 82
Pages: 409-419
Publication
First Author: Jamal R
Year: 2022
Journal: PLoS One
Title: Increased dosage and treatment time of Epigallocatechin-3-gallate (EGCG) negatively affects skeletal parameters in normal mice and Down syndrome mouse models.
Volume: 17
Issue: 2
Pages: e0264254
Publication
First Author: Ramakrishna N
Year: 2009
Journal: Neuroscience
Title: Upregulation of beta-catenin expression in down syndrome model Ts65Dn mouse brain.
Volume: 161
Issue: 2
Pages: 451-8
Publication  
First Author: Alldred MJ
Year: 2021
Journal: Front Aging Neurosci
Title: Oxidative Phosphorylation Is Dysregulated Within the Basocortical Circuit in a 6-month old Mouse Model of Down Syndrome and Alzheimer's Disease.
Volume: 13
Pages: 707950
Publication
First Author: Scott-McKean JJ
Year: 2010
Journal: Invest Ophthalmol Vis Sci
Title: The mouse model of Down syndrome Ts65Dn presents visual deficits as assessed by pattern visual evoked potentials.
Volume: 51
Issue: 6
Pages: 3300-8
Publication  
First Author: Begenisic T
Year: 2014
Journal: Neurobiol Dis
Title: Fluoxetine in adulthood normalizes GABA release and rescues hippocampal synaptic plasticity and spatial memory in a mouse model of Down syndrome.
Volume: 63
Pages: 12-9
Publication
First Author: Harashima C
Year: 2006
Journal: J Comp Neurol
Title: Abnormal expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in hippocampus, frontal cortex, and substantia nigra of Ts65Dn mouse: a model of Down syndrome.
Volume: 494
Issue: 5
Pages: 815-33
Publication  
First Author: Dekker AD
Year: 2017
Journal: Neurobiol Dis
Title: Aging rather than aneuploidy affects monoamine neurotransmitters in brain regions of Down syndrome mouse models.
Volume: 105
Pages: 235-244
Publication  
First Author: Day SM
Year: 2019
Journal: eNeuro
Title: Glucagon-Like Peptide-1 Cleavage Product Improves Cognitive Function in a Mouse Model of Down Syndrome.
Volume: 6
Issue: 2
Publication  
First Author: Davisson MT
Year: 1999
Journal: Adv Neurochem
Title: Mouse models of Down Syndrome
Volume: 9
Pages: 297-327
Publication
First Author: Das I
Year: 2013
Journal: Sci Transl Med
Title: Hedgehog agonist therapy corrects structural and cognitive deficits in a Down syndrome mouse model.
Volume: 5
Issue: 201
Pages: 201ra120
Publication  
First Author: Altafaj X
Year: 2013
Journal: Neurobiol Dis
Title: Normalization of Dyrk1A expression by AAV2/1-shDyrk1A attenuates hippocampal-dependent defects in the Ts65Dn mouse model of Down syndrome.
Volume: 52
Pages: 117-27
Publication
First Author: Hampton TG
Year: 2004
Journal: Physiol Behav
Title: Gait dynamics in trisomic mice: quantitative neurological traits of Down syndrome.
Volume: 82
Issue: 2-3
Pages: 381-9
Publication
First Author: Moore CS
Year: 2006
Journal: Mamm Genome
Title: Postnatal lethality and cardiac anomalies in the Ts65Dn Down syndrome mouse model.
Volume: 17
Issue: 10
Pages: 1005-12
Publication  
First Author: Powers BE
Year: 2017
Journal: Neuroscience
Title: Maternal choline supplementation in a mouse model of Down syndrome: Effects on attention and nucleus basalis/substantia innominata neuron morphology in adult offspring.
Volume: 340
Pages: 501-514
Publication
First Author: Chen Y
Year: 2009
Journal: Neurobiol Aging
Title: In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model.
Volume: 30
Issue: 9
Pages: 1453-65
Publication
First Author: Siarey RJ
Year: 1999
Journal: Neuropharmacology
Title: Increased synaptic depression in the Ts65Dn mouse, a model for mental retardation in Down syndrome.
Volume: 38
Issue: 12
Pages: 1917-20
Publication
First Author: Tyler WA
Year: 2013
Journal: J Neurosci
Title: Multiplex genetic fate mapping reveals a novel route of neocortical neurogenesis, which is altered in the Ts65Dn mouse model of Down syndrome.
Volume: 33
Issue: 12
Pages: 5106-19
Publication
First Author: Lysenko LV
Year: 2014
Journal: PLoS One
Title: Monoacylglycerol lipase inhibitor JZL184 improves behavior and neural properties in Ts65Dn mice, a model of down syndrome.
Volume: 9
Issue: 12
Pages: e114521
Publication  
First Author: Di Franco N
Year: 2022
Journal: Mol Cell Neurosci
Title: Differential expression of the neuronal CB1 cannabinoid receptor in the hippocampus of male Ts65Dn Down syndrome mouse model.
Volume: 119
Pages: 103705
Publication
First Author: Williams AD
Year: 2008
Journal: Dev Dyn
Title: Characterization of the cardiac phenotype in neonatal Ts65Dn mice.
Volume: 237
Issue: 2
Pages: 426-35
Publication
First Author: Sansevero G
Year: 2016
Journal: Exp Neurol
Title: Experience-dependent reduction of soluble β-amyloid oligomers and rescue of cognitive abilities in middle-age Ts65Dn mice, a model of Down syndrome.
Volume: 283
Issue: Pt A
Pages: 49-56
Publication
First Author: Kahlem P
Year: 2004
Journal: Genome Res
Title: Transcript level alterations reflect gene dosage effects across multiple tissues in a mouse model of down syndrome.
Volume: 14
Issue: 7
Pages: 1258-67
Publication
First Author: Starbuck JM
Year: 2021
Journal: Sci Rep
Title: Green tea extracts containing epigallocatechin-3-gallate modulate facial development in Down syndrome.
Volume: 11
Issue: 1
Pages: 4715
Publication
First Author: Lyle R
Year: 2004
Journal: Genome Res
Title: Gene expression from the aneuploid chromosome in a trisomy mouse model of down syndrome.
Volume: 14
Issue: 7
Pages: 1268-74
Publication
First Author: Wenger GR
Year: 2004
Journal: Behav Genet
Title: Operant conditioning in the Ts65Dn mouse: learning.
Volume: 34
Issue: 1
Pages: 105-19
Publication
First Author: Hunter CL
Year: 2004
Journal: Neurobiol Aging
Title: Behavioral and neurobiological markers of Alzheimer's disease in Ts65Dn mice: effects of estrogen.
Volume: 25
Issue: 7
Pages: 873-84
Publication
First Author: Alldred MJ
Year: 2019
Journal: FASEB J
Title: Long-term effects of maternal choline supplementation on CA1 pyramidal neuron gene expression in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.
Volume: 33
Issue: 9
Pages: 9871-9884
Publication
First Author: O'Leary DA
Year: 2004
Journal: Biochim Biophys Acta
Title: Tissue-specific overexpression of the HSA21 gene GABPalpha: implications for DS.
Volume: 1739
Issue: 1
Pages: 81-7
Publication
First Author: Stasko MR
Year: 2004
Journal: Behav Brain Res
Title: Experimental parameters affecting the Morris water maze performance of a mouse model of Down syndrome.
Volume: 154
Issue: 1
Pages: 1-17
Publication
First Author: Kleschevnikov AM
Year: 2004
Journal: J Neurosci
Title: Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome.
Volume: 24
Issue: 37
Pages: 8153-60
Publication  
First Author: Trazzi S
Year: 2014
Journal: Neurobiol Dis
Title: APP-dependent alteration of GSK3β activity impairs neurogenesis in the Ts65Dn mouse model of Down syndrome.
Volume: 67
Pages: 24-36
Publication
First Author: Cowley PM
Year: 2012
Journal: Am J Physiol Regul Integr Comp Physiol
Title: Functional and biochemical characterization of soleus muscle in Down syndrome mice: insight into the muscle dysfunction seen in the human condition.
Volume: 303
Issue: 12
Pages: R1251-60
Publication
First Author: Blazek JD
Year: 2010
Journal: Dev Dyn
Title: Embryonic and not maternal trisomy causes developmental attenuation in the Ts65Dn mouse model for Down syndrome.
Volume: 239
Issue: 6
Pages: 1645-53
Publication
First Author: Hunter CL
Year: 2003
Journal: Neurosci Res
Title: Regional alterations in amyloid precursor protein and nerve growth factor across age in a mouse model of Down's syndrome.
Volume: 45
Issue: 4
Pages: 437-45
Publication
First Author: Saran NG
Year: 2003
Journal: Hum Mol Genet
Title: Global disruption of the cerebellar transcriptome in a Down syndrome mouse model.
Volume: 12
Issue: 16
Pages: 2013-9
Publication
First Author: Bimonte-Nelson HA
Year: 2003
Journal: Behav Brain Res
Title: Frontal cortex BDNF levels correlate with working memory in an animal model of Down syndrome.
Volume: 139
Issue: 1-2
Pages: 47-57
Publication
First Author: Victorino DB
Year: 2021
Journal: Sci Rep
Title: Atypical electrophysiological and behavioral responses to diazepam in a leading mouse model of Down syndrome.
Volume: 11
Issue: 1
Pages: 9521
Publication  
First Author: Catuara-Solarz S
Year: 2015
Journal: Front Behav Neurosci
Title: Principal Component Analysis of the Effects of Environmental Enrichment and (-)-epigallocatechin-3-gallate on Age-Associated Learning Deficits in a Mouse Model of Down Syndrome.
Volume: 9
Pages: 330
Publication
First Author: Llambrich S
Year: 2020
Journal: Sci Rep
Title: ViceCT and whiceCT for simultaneous high-resolution visualization of craniofacial, brain and ventricular anatomy from micro-computed tomography.
Volume: 10
Issue: 1
Pages: 18772
Publication
First Author: Shetty HU
Year: 2000
Journal: Neurochem Res
Title: Ts65Dn mouse, a Down syndrome model, exhibits elevated myo-inositol in selected brain regions and peripheral tissues.
Volume: 25
Issue: 4
Pages: 431-5
Publication
First Author: Akeson EC
Year: 2001
Journal: Cytogenet Cell Genet
Title: Ts65Dn -- localization of the translocation breakpoint and trisomic gene content in a mouse model for Down syndrome.
Volume: 93
Issue: 3-4
Pages: 270-6
Publication
First Author: Kurt MA
Year: 2004
Journal: Brain Res
Title: Deficits of neuronal density in CA1 and synaptic density in the dentate gyrus, CA3 and CA1, in a mouse model of Down syndrome.
Volume: 1022
Issue: 1-2
Pages: 101-9
Publication
First Author: Chrast R
Year: 2000
Journal: Genome Res
Title: The mouse brain transcriptome by SAGE: differences in gene expression between P30 brains of the partial trisomy 16 mouse model of Down syndrome (Ts65Dn) and normals.
Volume: 10
Issue: 12
Pages: 2006-21
Publication
First Author: Möhler H
Year: 2012
Journal: Biochem Pharmacol
Title: Cognitive enhancement by pharmacological and behavioral interventions: the murine Down syndrome model.
Volume: 84
Issue: 8
Pages: 994-9
Publication
First Author: Megías M
Year: 1997
Journal: Neuroreport
Title: Cholinergic, serotonergic and catecholaminergic neurons are not affected in Ts65Dn mice.
Volume: 8
Issue: 16
Pages: 3475-8
Publication  
First Author: Begenisic T
Year: 2011
Journal: Front Cell Neurosci
Title: Environmental enrichment decreases GABAergic inhibition and improves cognitive abilities, synaptic plasticity, and visual functions in a mouse model of Down syndrome.
Volume: 5
Pages: 29